Nokea
Frusemide is:
- A. A loop diuretic
- B. Osmotic diuretic
- C. Aldosterone antagonist
- D. A carbonic anhydrase inhibitor
Correct Answer: A
Rationale: Furosemide (Frusemide) is a loop diuretic that inhibits sodium and chloride reabsorption in the loop of Henle, leading to increased urine output.
You may also like to solve these questions
Medication agreements or 'Pain Medication Contracts' are recommended to be used:
- A. Universally for all prescribing for chronic pain
- B. For patients who have repeated requests for pain medication
- C. When you suspect a patient is exhibiting drug-seeking behavior
- D. For patients with pain associated with malignancy
Correct Answer: A
Rationale: Pain contracts are recommended universally for chronic pain to set expectations, not just for repeated requests , suspicion , or cancer .
Digoxin levels need to be monitored closely when the following medication is started:
- A. Loratadine
- B. Diphenhydramine
- C. Ipratropium
- D. Albuterol
Correct Answer: D
Rationale: Albuterol , a beta-agonist, can increase digoxin levels by enhancing its effects, requiring close monitoring; antihistamines and ipratropium have minimal impact.
Indirect costs associated with drug therapy include:
- A. The cost of diagnostic tests to monitor therapeutic levels
- B. Health-care provider time to prescribe and educate the patient
- C. Child-care expenses incurred while receiving therapy
- D. Loss of wages while undergoing drug therapy
Correct Answer: D
Rationale: Indirect costs include societal impacts like lost wages due to treatment.
The FDA issued a safety announcement regarding the use of erythropoiesis-stimulating agents (ESAs) in 2010 with the recommendation that:
- A. ESAs no longer be prescribed to patients with chronic renal failure
- B. The risk of tumor development be explained to cancer patients on ESA therapy
- C. Patients should no longer receive ESA therapy to prepare for allogenic transfusions
- D. ESAs be prescribed only to patients staying
Correct Answer: B
Rationale: The 2010 FDA warning highlighted tumor progression risks in cancer patients on ESAs; renal use continues with caution.
Serum level of drug is monitored when the patient is on
- A. Lithium
- B. Haloperidol
- C. Diazepam
- D. Acetazolamide
Correct Answer: A
Rationale: Lithium requires monitoring due to its narrow therapeutic range.